Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report

A 59-year-old Japanese woman was admitted for evaluation of muscle weakness. Autosomal dominant polycystic kidney disease had been diagnosed at the age of 47 years, followed by primary aldosteronism at 53 years. At the age of 58, tolvaptan was started (60 mg/day) to treat her renal disease. After 8...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Case Rep Nephrol Dial
Главные авторы: Kunizawa, Kyohei, Hoshino, Junichi, Mizuno, Hiroki, Suwabe, Tatsuya, Sumida, Keiichi, Kawada, Masahiro, Yamanouchi, Masayuki, Sekine, Akinari, Hayami, Noriko, Hiramatsu, Rikako, Hasegawa, Eiko, Sawa, Naoki, Takaichi, Kenmei, Shibata, Shigeru, Ubara, Yoshifumi
Формат: Artigo
Язык:Inglês
Опубликовано: S. Karger AG 2018
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5903093/
https://ncbi.nlm.nih.gov/pubmed/29692992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487921
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы